Market Overview:
The global mevalonic acid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for drugs and chemicals, and rising investments in R&D activities. The L-Mevalonic acid segment is expected to dominate the market during the forecast period, owing to its high demand in drug production. In terms of application, the drugs segment is projected to lead the global mevalonic acid market during 2018-2030.
Product Definition:
Mevalonic acid is a naturally occurring compound that is important in the biosynthesis of terpenes and sterols.
L-Mevalonic Acid:
Mevalonic acid also called 4-oxopentanoic acid is an organic compound that is classified as a ketoacid. It has a pKa of 8.4 and forms salt with any base, such as potassium hydroxide or sodium hydroxide. The compound can be synthesized by chemical synthesis or fermentation (biotechnological).
Others:
Others are the other organic compounds which are not classified as a chemical substance. The Others segment includes various sub-segments such as, polyphenols, amino acids and natural products. Mevalonic acid is one of the important Others in myriant market which has wide range of applications such as pharmaceuticals and fine chemicals.
Mevonic acid is an organic compound that is produced by several microorganisms including bacteria.
Application Insights:
The drugs segment dominated the global market in 2017. Mevalonic acid is used as a raw material for the manufacturing of various drugs including antidepressants, antipsychotics, anticonvulsants and anti-inflammatory agents. The growing use of mental health therapies owing to increasing awareness about depression and other mental disorders is expected to drive growth over the forecast period.
Mevalonate salts are widely used in drug formulations due to their lipophilicity and solubility properties which help enhance absorption through oral administration. They are also employed as intermediates for several steps in drug formulation such as esterification, amidation & amide formation which further leads to improved patient compliance with medication dosages leading to increased demand globally over the forecast period.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The region is also anticipated to be one of the fastest-growing regions during the forecast years. This growth can be attributed to increasing demand for miscellaneous products from various industries, such as construction, electronics, and textile.
The presence of a large number of manufacturers in Asia Pacific has led to increased production capacities for miscellaneous products as well as downstream chemical entities across major countries including China, India, Japan, South Korea & Taiwan. These factors are anticipated to drive regional product demand over the next eight years.
In terms of revenue share within Asia Pacific market space; South Korea emerged dominant with a volume share of 23% in 2017 owing mainlyto growing exports from domestic manufacturers along with rising R&D activities by foreign players operating outstide Korean borders (i.e., China).
Growth Factors:
- Increasing demand for Mevalonic Acid in the pharmaceutical and biotechnology industries for the manufacture of various drugs and vaccines.
- Growing demand from cosmetics industry for the formulation of skin care products.
- Rising application of Mevalonic Acid in nutraceuticals and dietary supplements owing to its health benefits.
- Increasing research activities on Mevalonic Acid derivatives for potential therapeutic applications in various diseases such as cancer, diabetes, etc.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mevalonic Acid Market Research Report
By Type
L-Mevalonic Acid, Others
By Application
Drugs, Chemical Production, Others
By Companies
Sigma-Aldrich, Carbosynth Product, TLC Pharmaceutical, Rinner Group, Tocris Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Mevalonic Acid Market Report Segments:
The global Mevalonic Acid market is segmented on the basis of:
Types
L-Mevalonic Acid, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drugs, Chemical Production, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sigma-Aldrich
- Carbosynth Product
- TLC Pharmaceutical
- Rinner Group
- Tocris Bioscience
Highlights of The Mevalonic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- L-Mevalonic Acid
- Others
- By Application:
- Drugs
- Chemical Production
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mevalonic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mevalonic acid is a type of organic compound that is found in small amounts in many foods. It is also produced naturally by the body. Mevalonic acid has been shown to have antioxidant properties and may help protect against heart disease, cancer, and other diseases.
Some of the major companies in the mevalonic acid market are Sigma-Aldrich, Carbosynth Product, TLC Pharmaceutical, Rinner Group, Tocris Bioscience.
The mevalonic acid market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mevalonic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mevalonic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mevalonic Acid Market - Supply Chain
4.5. Global Mevalonic Acid Market Forecast
4.5.1. Mevalonic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mevalonic Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mevalonic Acid Market Absolute $ Opportunity
5. Global Mevalonic Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mevalonic Acid Market Size and Volume Forecast by Type
5.3.1. L-Mevalonic Acid
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mevalonic Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mevalonic Acid Market Size and Volume Forecast by Application
6.3.1. Drugs
6.3.2. Chemical Production
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mevalonic Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mevalonic Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mevalonic Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mevalonic Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mevalonic Acid Demand Share Forecast, 2019-2026
9. North America Mevalonic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mevalonic Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mevalonic Acid Market Size and Volume Forecast by Application
9.4.1. Drugs
9.4.2. Chemical Production
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mevalonic Acid Market Size and Volume Forecast by Type
9.7.1. L-Mevalonic Acid
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mevalonic Acid Demand Share Forecast, 2019-2026
10. Latin America Mevalonic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mevalonic Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mevalonic Acid Market Size and Volume Forecast by Application
10.4.1. Drugs
10.4.2. Chemical Production
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mevalonic Acid Market Size and Volume Forecast by Type
10.7.1. L-Mevalonic Acid
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mevalonic Acid Demand Share Forecast, 2019-2026
11. Europe Mevalonic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mevalonic Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mevalonic Acid Market Size and Volume Forecast by Application
11.4.1. Drugs
11.4.2. Chemical Production
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mevalonic Acid Market Size and Volume Forecast by Type
11.7.1. L-Mevalonic Acid
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mevalonic Acid Demand Share, 2019-2026
12. Asia Pacific Mevalonic Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mevalonic Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mevalonic Acid Market Size and Volume Forecast by Application
12.4.1. Drugs
12.4.2. Chemical Production
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mevalonic Acid Market Size and Volume Forecast by Type
12.7.1. L-Mevalonic Acid
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mevalonic Acid Demand Share, 2019-2026
13. Middle East & Africa Mevalonic Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mevalonic Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mevalonic Acid Market Size and Volume Forecast by Application
13.4.1. Drugs
13.4.2. Chemical Production
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mevalonic Acid Market Size and Volume Forecast by Type
13.7.1. L-Mevalonic Acid
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mevalonic Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mevalonic Acid Market: Market Share Analysis
14.2. Mevalonic Acid Distributors and Customers
14.3. Mevalonic Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sigma-Aldrich
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Carbosynth Product
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. TLC Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Rinner Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tocris Bioscience
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
